Erratum: Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodies (European Journal of Immunology (2008) vol. 38 (7) 10.1002/eji.200737784);Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodies

European Journal of Immunology

Volumn 38, Issue 7, 2008, Pages 2014-2023

  von Büdingen, Hans Christian ^a   Harrer, Melanie D ^a   Kuenzle, Sandra ^a   Meier, Mirjam ^a   Goebels, Norbert ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Cerebrospinal fluid; Multiple sclerosis; Myelin; Plasma cells; Recombinant antibodies

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MS; MYELIN; OLIGOCLONAL BAND; UNCLASSIFIED DRUG; AUTOANTIBODY;

ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; ASTROCYTE; CASE REPORT; CELL FUNCTION; CEREBROSPINAL FLUID; CLONALLY EXPANDED PLASMA CELL; CONTROLLED STUDY; DEMYELINATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MALE; MULTIPLE SCLEROSIS; MYELINATED NERVE; PLASMA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WHITE MATTER; ADULT; BRAIN; COLON; CYTOLOGY; IMMUNOLOGY; LYMPH NODE; METABOLISM; MIDDLE AGED; MYELIN SHEATH; PATHOLOGY;

ADULT; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; BRAIN; CEREBROSPINAL FLUID; COLON; FEMALE; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN SHEATH; PLASMA CELLS;

EID: 50549098924     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200890030     Document Type: Erratum

References (45)

1. Link, H., The immune response in human demyelinating diseases. Adv. Exp. Med. Biol. 1978. 100: 529-543.
2. Tourtellotte, W. W., Potvin, A. R., Fleming, J. O., Murthy, K. N., Levy, J., Syndulko, K. and Potvin, J. H., Multiple sclerosis: Measurement and validation of central nervous system IgG synthesis rate. Neurology 1980. 30: 240-244.
3. Storch, M. K., Piddlesden, S., Haltia, M., Iivanainen, M., Morgan, P. and Lassmann, H., Multiple sclerosis: In situ evidence for antibody- and complement-mediated demyelination. Ann. Neurol. 1998. 43: 465-471.
4. Baranzini, S. E., Jeong, M. C., Butunoi, C., Murray, R. S., Bernard, C. C. and Oksenberg, J. R., B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. J. Immunol. 1999. 163: 5133-5144.
5. Genain, C. P., Nguyen, M. H., Letvin, N. L., Pearl, R., Davis, R. L., Adelman, M., Lees, M. B. et al., Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J. Clin. Invest. 1995. 96: 2966-2974.
6. Piddlesden, S. J., Lassmann, H., Zimprich, F., Morgan, B. P. and Linington, C., The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am. J. Pathol. 1993. 143: 555-564.
7. von büdingen, H. C., Hauser, S. L., Ouallet, J. C., Tanuma, N., Menge, T. and Genain, C. P., Epitope recognition on the myelin/ oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination. Eur. J. Immunol. 2004. 34: 2072-2083.
8. Karni, A., Bakimer-Kleiner, R., Abramsky, O. and Ben-Nun, A., Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis. Arch. Neurol. 1999. 56: 311-315.
9. Kuhle, J., Pohl, C., Mehling, M., Edan, G., Freedman, M. S., Hartung, H. P., Polman, C. H. et al., Lack of association between antimyelin antibodies and progression to multiple sclerosis. N. Engl. J. Med. 2007. 356: 371-378.
10. Lindert, R. B., Haase, C. G., Brehm, U., Linington, C., Wekerle, H. and Hohlfeld, R., Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein. Brain 1999. 122: 2089-2100.
11. Mantegazza, R., Cristaldini, P., Bernasconi, P., Baggi, F., Pedotti, R., Piccini, I., Mascoli, N. et al., Anti-MOG autoantibodies in Italian multiple sclerosis patients: Specificity, sensitivity and clinical association. Int. Immunol. 2004. 16: 559-565.
12. Markovic, M., Trajkovic, V., Drulovic, J., Mesaros, S., Stojsavljevic, N., Dujmovic, I. and Mostarica Stojkovic, M., Antibodies against myelin oligodendrocyte glycoprotein in the cerebrospinal fluid of multiple sclerosis patients. J. Neurol. Sci. 2003. 211: 67-73.
13. Reindl, M., Linington, C., Brehm, U., Egg, R., Dilitz, E., Deisenhammer, F., Poewe, W. and Berger, T., Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: A comparative study. Brain 1999. 122: 2047-2056.
14. Sun, J., Link, H., Olsson, T., Xiao, B. G., Andersson, G., Ekre, H. P., Linington, C. and Diener, P., T and B cell responses to myelinoligodendrocyte glycoprotein in multiple sclerosis. J. Immunol. 1991. 146: 1490-1495.
15. Xiao, B. G., Linington, C. and Link, H., Antibodies to myelinoligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. J. Neuroimmunol. 1991. 31: 91-96.
16. + cell antibody repertoires in the cerebrospinal fluid of patients with multiple sclerosis. J. Immunol. 2004. 173: 649-656.
17. Cepok, S., Rosche, B., Grummel, V., Vogel, F., Zhou, D., Sayn, J., Sommer, N. et al., Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain 2005. 128: 1667-1676.
18. Corcione, A., Aloisi, F., Serafini, B., Capello, E., Mancardi, G. L., Pistoia, V. and Uccelli, A., B-cell differentiation in the CNS of patients with multiple sclerosis. Autoimmun. Rev. 2005. 4: 549-554.
19. Meinl, E., Krumbholz, M. and Hohlfeld, R., B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation. Ann. Neurol. 2006. 59: 880-892.
20. Cross, A. H., Stark, J. L., Lauber, J., Ramsbottom, M. J. and Lyons, J. A., Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients. J. Neuroimmunol. 2006. 180: 63-70.
21. Monson, N. L., Cravens, P. D., Frohman, E. M., Hawker, K. and Racke, M. K., Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis. Arch. Neurol. 2005. 62: 258-264.
22. Stuve, O., Marra, C.M., Jerome, K. R., Cook, L., Cravens, P. D., Cepok, S., Frohman, E. M. et al., Immune surveillance in multiple sclerosis patients treated with natalizumab. Ann. Neurol. 2006. 59: 743-747.
23. Owens, G. P., Kraus, H., Burgoon, M. P., Smith-Jensen, T., Devlin, M. E. and Gilden, D. H., Restricted use of VH4 germline segments in an acute multiple sclerosis brain. Ann. Neurol. 1998. 43: 236-243.
24. Owens, G. P., Ritchie, A. M., Burgoon, M. P., Williamson, R. A., Corboy, J. R. and Gilden, D. H., Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid. J. Immunol. 2003. 171: 2725-2733.
25. Burgoon, M. P., Keays, K. M., Owens, G. P., Ritchie, A. M., Rai, P. R., Cool, C. D. and Gilden, D. H., Laser-capture microdissection of plasma cells from subacute sclerosing panencephalitis brain reveals intrathecal disease-relevant antibodies. Proc. Natl. Acad. Sci. USA 2005. 102: 7245-7250.
26. Kuenzle, S., von Büdingen, H. C., Meier, M., Harrer, M. D., Urich, E., Becher, B. and Goebels, N., Pathogen specificity and autoimmunity are distinct features of antigen driven immune responses in neuroborreliosis. Infect. Immun. 2007. 75: 3842-3847.
27. Brunner, C., Lassmann, H., Waehneldt, T. V., Matthieu, J. M. and Linington, C., Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 20′,30′-cyclic nucleotide 3′-phosphodiesterase in the CNS of adult rats. J. Neurochem. 1989. 52: 296-304.
28. Marta, C. B., Oliver, A. R., Sweet, R. A., Pfeiffer, S. E. and Ruddle, N. H., Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology. Proc. Natl. Acad. Sci. USA 2005. 102: 13992-13997.
29. Berger, T., Rubner, P., Schautzer, F., Egg, R., Ulmer, H., Mayringer, I., Dilitz, E. et al., Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N. Engl. J. Med. 2003. 349: 139-145.
30. Cepok, S., Zhou, D., Srivastava, R., Nessler, S., Stei, S., Bussow, K., Sommer, N. and Hemmer, B., Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J. Clin. Invest. 2005. 115: 1352-1360.
31. Franciotta, D., Zardini, E., Bergamaschi, R., Grimaldi, L. M., Andreoni, L. and Cosi, V., Analysis of Chlamydia pneumoniae-specific oligoclonal bands in multiple sclerosis and other neurologic diseases. Acta Neurol. Scand. 2005. 112: 238-241.
32. Zhang, Y., Da, R. R., Guo, W., Ren, H. M., Hilgenberg, L. G., Sobel, R. A., Tourtellotte, W. W. et al., Axon reactive B cells clonally expanded in the cerebrospinal fluid of patients with multiple sclerosis. J. Clin. Immunol. 2005. 25: 254-264.
33. Yu, X., Gilden, D. H., Ritchie, A. M., Burgoon, M. P., Keays, K. M. and Owens, G. P., Specificity of recombinant antibodies generated from multiple sclerosis cerebrospinal fluid probed with a random peptide library. J. Neuroimmunol. 2006. 172: 121-131
34. Lambracht-Washington, D., O'Connor, K. C., Cameron, E. M., Jowdry, A., Ward, E. S., Frohman, E., Racke, M. K. and Monson, N. L., Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MS. J. Neuroimmunol. 2007. 186: 164-176.
35. Lucchinetti, C., Bruck, W., Parisi, J., Scheithauer, B., Rodriguez, M. and Lassmann, H., Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann. Neurol. 2000. 47: 707-717.
36. Genain, C. P., Cannella, B., Hauser, S. L. and Raine, C. S., Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 1999. 5: 170-175.
37. Schluesener, H. J., Sobel, R. A., Linington, C. and Weiner, H. L., A monoclonal antibody against amyelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J. Immunol. 1987. 139: 4016-4021.
38. Kabat, E. A., Wolf, A. and Bezer, A. E., The rapid production of acute disseminated encephalomyelitis in rhesus monkeys by injection of heterologous and homologous brain tissue with adjuvans. J. Exp. Med. 1947. 85: 117-130.
39. Kanter, J. L., Narayana, S., Ho, P. P., Catz, I., Warren, K. G., Sobel, R. A., Steinman, L. and Robinson, W. H., Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat. Med. 2006. 12: 138-143.
40. Menge, T., Lalive, P. H., von Büdingen, H. C., Cree, B., Hauser, S. L. and Genain, C. P., Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis. J. Allergy Clin. Immunol. 2005. 116: 453-459.
41. Wucherpfennig, K. W. and Strominger, J. L., Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995. 80: 695-705.
42. Rosen, A. and Casciola-Rosen, L., Clearing the way to mechanisms of autoimmunity. Nat. Med. 2001. 7: 664-665.
43. Krumbholz, M., Theil, D., Cepok, S., Hemmer, B., Kivisakk, P., Ransohoff, R. M., Hofbauer, M. et al., Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 2006. 129: 200-211.
44. Giudicelli, V., Chaume, D. and Lefranc, M. P., IMGT/V-QUEST, an integrated software program for immunoglobulin and Tcell receptor V-J and V-D-J rearrangement analysis. Nucleic Acids Res. 2004. 32: W435-W440.
45. Wardemann, H., Yurasov, S., Schaefer, A., Young, J. W., Meffre, E. and Nussenzweig, M. C., Predominant autoantibody production by early human B cell precursors. Science 2003. 301: 1374-1377.